Kewaunee Scientific Corp
NASDAQ:KEQU
Kewaunee Scientific Corp
Revenue
Kewaunee Scientific Corp
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kewaunee Scientific Corp
NASDAQ:KEQU
|
Revenue
$201m
|
CAGR 3-Years
12%
|
CAGR 5-Years
5%
|
CAGR 10-Years
6%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Kewaunee Scientific Corp
Revenue Breakdown
Breakdown by Geography
Kewaunee Scientific Corp
Breakdown by Segments
Kewaunee Scientific Corp
Total Revenue:
219.5m
USD
|
International Operations:
155.4m
USD
|
Domestic Operations:
150.9m
USD
|
See Also
What is Kewaunee Scientific Corp's Revenue?
Revenue
201m
USD
Based on the financial report for Jan 31, 2024, Kewaunee Scientific Corp's Revenue amounts to 201m USD.
What is Kewaunee Scientific Corp's Revenue growth rate?
Revenue CAGR 10Y
6%
Over the last year, the Revenue growth was -7%. The average annual Revenue growth rates for Kewaunee Scientific Corp have been 12% over the past three years , 5% over the past five years , and 6% over the past ten years .